Aviance Capital Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $458K | Sell |
5,287
-30
| -0.6% | -$2.87K | 0.05% | 251 |
|
|
2025
Q4 | $511K | Sell |
5,317
-404
| -7% | -$39.2K | 0.06% | 232 |
|
|
2025
Q3 | $545K | Buy |
5,721
+339
| +6% | +$31.2K | 0.06% | 223 |
|
|
2025
Q2 | $469K | Buy |
5,382
+858
| +19% | +$72.8K | 0.06% | 229 |
|
|
2025
Q1 | $407K | Buy |
4,524
+148
| +3% | +$13.2K | 0.06% | 237 |
|
|
2024
Q4 | $350K | Buy |
4,376
+396
| +10% | +$34.3K | 0.05% | 247 |
|
|
2024
Q3 | $358K | Sell |
3,980
-79
| -2% | -$6.65K | 0.05% | 257 |
|
|
2024
Q2 | $319K | Buy |
4,059
+468
| +13% | +$38.4K | 0.05% | 255 |
|
|
2024
Q1 | $313K | Buy |
3,591
+41
| +1% | +$3.5K | 0.05% | 257 |
|
|
2023
Q4 | $292K | Sell |
3,550
-200
| -5% | -$15.2K | 0.06% | 208 |
|
|
2023
Q3 | $294K | Hold |
3,750
| – | – | 0.07% | 207 |
|
|
2023
Q2 | $330K | Buy |
3,750
+232
| +7% | +$20K | 0.07% | 208 |
|
|
2023
Q1 | $284K | Buy |
3,518
+48
| +1% | +$3.91K | 0.06% | 224 |
|
|
2022
Q4 | $270K | Sell |
3,470
-173
| -5% | -$14K | 0.06% | 236 |
|
|
2022
Q3 | $294K | Hold |
3,643
| – | – | 0.07% | 212 |
|
|
2022
Q2 | $327K | Hold |
3,643
| – | – | 0.07% | 210 |
|
|
2022
Q1 | $404K | Sell |
3,643
-24
| -0.7% | -$2.54K | 0.07% | 197 |
|
|
2021
Q4 | $379K | Sell |
3,667
-23
| -0.6% | -$2.66K | 0.06% | 208 |
|
|
2021
Q3 | $463K | Sell |
3,690
-75
| -2% | -$9.71K | 0.08% | 193 |
|
|
2021
Q2 | $467K | Sell |
3,765
-56
| -1% | -$7.03K | 0.08% | 193 |
|
|
2021
Q1 | $451K | Sell |
3,821
-222
| -5% | -$26K | 0.09% | 202 |
|
|
2020
Q4 | $474K | Hold |
4,043
| – | – | 0.1% | 183 |
|
|
2020
Q3 | $420K | Hold |
4,043
| – | – | 0.09% | 178 |
|
|
2020
Q2 | $371K | Sell |
4,043
-191
| -5% | -$18.3K | 0.09% | 183 |
|
|
2020
Q1 | $382K | Sell |
4,234
-664
| -14% | -$70.6K | 0.12% | 165 |
|
|
2019
Q4 | $556K | Hold |
4,898
| – | – | 0.14% | 151 |
|
|
2019
Q3 | $532K | Sell |
4,898
-200
| -4% | -$20.9K | 0.16% | 147 |
|
|
2019
Q2 | $496K | Buy |
5,098
+247
| +5% | +$22.6K | 0.14% | 164 |
|
|
2019
Q1 | $442K | Sell |
4,851
-10
| -0.2% | -$895 | 0.13% | 165 |
|
|
2018
Q4 | $442K | Sell |
4,861
-790
| -14% | -$73.8K | 0.16% | 151 |
|
|
2018
Q3 | $556K | Hold |
5,651
| – | – | 0.13% | 158 |
|
|
2018
Q2 | $483K | Sell |
5,651
-11,000
| -66% | -$919K | 0.14% | 169 |
|
|
2018
Q1 | $1.33M | Sell |
16,651
-3,591
| -18% | -$296K | 0.4% | 66 |
|
|
2017
Q4 | $1.64M | Sell |
20,242
-1,000
| -5% | -$80.1K | 0.54% | 51 |
|
|
2017
Q3 | $1.65M | Sell |
21,242
-900
| -4% | -$74.7K | 0.56% | 48 |
|
|
2017
Q2 | $1.97M | Sell |
22,142
-145
| -0.7% | -$12.2K | 0.63% | 37 |
|
|
2017
Q1 | $1.79M | Sell |
22,287
-673
| -3% | -$52.6K | 0.66% | 37 |
|
|
2016
Q4 | $1.64M | Sell |
22,960
-3,537
| -13% | -$278K | 0.58% | 45 |
|
|
2016
Q3 | $2.29M | Buy |
26,497
+64
| +0.2% | +$5.58K | 0.81% | 32 |
|
|
2016
Q2 | $2.29M | Hold |
26,433
| – | – | 0.84% | 30 |
|
|
2016
Q1 | $1.98M | Sell |
26,433
-573
| -2% | -$43.2K | 0.69% | 33 |
|
|
2015
Q4 | $2.08M | Sell |
27,006
-1,053
| -4% | -$79.3K | 0.71% | 31 |
|
|
2015
Q3 | $1.88M | Sell |
28,059
-1,573
| -5% | -$116K | 0.77% | 30 |
|
|
2015
Q2 | $2.2M | Buy |
29,632
+290
| +1% | +$22.2K | 0.82% | 23 |
|
|
2015
Q1 | $2.29M | Buy |
29,342
+5,442
| +23% | +$412K | 0.84% | 24 |
|
|
2014
Q4 | $1.73M | Sell |
23,900
-500
| -2% | -$34.7K | 0.64% | 37 |
|
|
2014
Q3 | $1.51M | Buy |
24,400
+1,000
| +4% | +$63.6K | 0.57% | 42 |
|
|
2014
Q2 | $1.49M | Buy |
23,400
+7,500
| +47% | +$456K | 0.58% | 42 |
|
|
2014
Q1 | $978K | Hold |
15,900
| – | – | 0.41% | 63 |
|
|
2013
Q4 | $913K | Hold |
15,900
| – | – | 0.38% | 69 |
|
|
2013
Q3 | $847K | Sell |
15,900
-1,500
| -9% | -$80.7K | 0.4% | 67 |
|
|
2013
Q2 | $896K | Buy |
+17,400
| New | +$860K | 0.48% | 60 |
|
Other funds holding MDT
VCM
VPM
Aviance Capital Partners's MDT Position: Q1 2026 in Review
Aviance Capital Partners reduced its Medtronic (MDT) stake by 0.56% in Q1 2026, selling an estimated $2.87K and leaving 5,287 shares worth $458K. The position accounts for 0.05% of the portfolio, ranked #251.
Aviance Capital Partners first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.29M in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Aviance Capital Partners held 5,287 shares of Medtronic worth $458K as of Q1 2026.
- Aviance Capital Partners sold 30 Medtronic shares in Q1 2026, an estimated $2.87K.
- Medtronic made up 0.05% of Aviance Capital Partners's portfolio in Q1 2026, its #251 holding.
- Aviance Capital Partners first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Aviance Capital Partners's Medtronic position peaked at $2.29M in Q2 2016.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.